mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.07 |
0.7 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.7 |